Unmasking the silent killer to heart health: An evaluation of cardiometabolic risk and
screening in outpatient spinal cord injury rehabilitation

Luxshmi Nageswaran1,2, Dalton L. Wolfe1,2, Laura J. Graham1,3, Emma A. Bateman1,4
1 Parkwood
2 School
3

Institute Research, Lawson Health Research Institute, London, ON;

of Health Studies, Faculty of Health Sciences, Western University, London, ON;

School of Physical Therapy, Faculty of Health Sciences, Western University, London, ON;

4 Department

of Physical Medicine & Rehabilitation, Schulich School of Medicine &

Dentistry, Western University, London, ON

Abstract:
Objective: 1) Determine the prevalence of cardiometabolic disease (CMD) risk factors
in Canadian outpatients with spinal cord injury or disease (SCI/D); and 2) Augment
CMD screening practices to reflect evidence-based guidelines using quality
improvement initiatives.
Design: Chart audit of consecutive outpatients with SCI/D assessed after discharge
from Parkwood Institute between October 2020 to December 2021 (n=78). Data
collected included presence of and evidence-based screening for 4 CMD risk factors –
obesity, hypertension, dyslipidemia, diabetes mellitus. Definitions for presence of these
4 CMD risk factors were established using clinical practice guidelines for persons with
SCI/D.
Results: All CMD risk factors were highly prevalent amongst outpatients with SCI/D.
Two of every 5 outpatients had ≥ 3 risk factors, indicating the presence of established
CMD. Obesity was the most prevalent risk factor (84.2%), followed by dyslipidemia
(80.7%), hypertension (47.4%), and diabetes mellitus (44.6%). Outpatient clinic
screening for hypertension and obesity across 79 visits (n=43) was completed in 15.2%
and 11.4% of appointments respectively.
Conclusions: The strikingly high CMD risk factor prevalence in this cohort of Canadian
outpatients with SCI/D coupled with low screening rates in follow-up appointments
reinforces the need for strategies to reduce preventable harm in the rehabilitation
setting.
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Introduction:
Frequently referred to as a “silent killer”, cardiometabolic disease (CMD) is one of the
leading causes of morbidity and mortality in persons with spinal cord injury/disease
(SCI/D), yet persons with SCI/D are less likely to receive appropriate screening,
diagnosis, and treatment for this preventable condition. Moreover, CMD prevalence in
the Canadian SCI/D population and the implementation of targeted evidence-based
treatment guidelines in rehabilitation settings have been relatively under-researched.1–3
CMD encompasses a cluster of interrelated health risk factors that often develop slowly
and insidiously without overt symptoms and therefore may not be a priority in
rehabilitation, particularly when compared to more acute, symptomatic complications.1–4
As such, early detection and timely treatment will require conscientious efforts to bring
CMD risk reduction to the forefront before it is too late.

CMD is defined as the co-occurrence of 3 or more interrelated chronic conditions—
obesity, hypertension, dyslipidemia, and diabetes mellitus—which collectively contribute
to the development of diabetes mellitus, cardiovascular disease, and/or heart failure.1,3,5
It is comprised of inflammatory, renal, metabolic, and prothrombotic pathologies leading
to serious complications in essential regulatory processes in the body.1,5 The complex,
multisystem nature of SCI/D, impairments in the autonomic nervous system controlling
involuntary homeostatic processes, in combination with other factors related to lifestyle
changes (i.e., physical inactivity and decreased energy expenditure) have led many
studies to report a heightened prevalence of CMD risk and its related consequences in
the SCI/D population.3,4,6 Evidence has also shown that persons with SCI/D develop
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CMD at an accelerated rate and younger age in comparison to the non-SCI/D
population.7

Interrelated conditions contributing to the development of CMD have been identified as
key clinical determinants for prediction and/or diagnosis; the most well-known of these
are hypertension, obesity, dyslipidemia, and diabetes mellitus.1,3 Recently published
clinical practice guidelines, “Identification and Management of Cardiometabolic Risk
after Spinal Cord Injury,” deliver guidance on evaluating these 4 key CMD risk factors in
persons with SCI/D, specifically by providing rationale on identifiable biomarkers,
methods for risk stratification, and recommendations for routine screening.1 In particular,
the screening of all 4 risk factors is recommended during inpatient rehabilitation, with
routine tests in the outpatient setting to be completed at every visit for hypertension and
obesity and on an annual basis for dyslipidemia and diabetes mellitus.1 Evaluating the
gap between current practices and guideline recommendations is essential to identify
gaps in care and areas for improvement.8 As such, the purpose of this study was to
evaluate the prevalence of CMD risk factors in a Canadian sample of outpatients with
SCI/D at Parkwood Institute, determine the current rate of guidelines-based screening,
and identify areas for improvement in institutional screening practices to inform targeted
quality improvement strategies promoting heart health.

Ethics:
This study underwent institutional Research Ethics Board (REB) evaluation and
received REB exemption as a quality improvement initiative.
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Methods:
A retrospective chart review was conducted on a convenience sample of consecutive
outpatients with traumatic and non-traumatic SCI/D who were seen for an initial
assessment at the Parkwood Institute outpatient clinic after discharge from inpatient
rehabilitation between October 2020 to December 2021. Data collected included age,
sex, and clinical data related to the prevalence at admission to and/or discharge from
inpatient rehabilitation for the 4 key CMD risk factors – hypertension, obesity,
dyslipidemia, diabetes mellitus.. Hypertension and obesity were assessed using blood
pressure (systolic/diastolic) and body mass index (BMI) measurements, respectively.
Dyslipidemia and diabetes mellitus were evaluated using data from lipid and glycated
hemoglobin (HbA1c) blood tests conducted upon admission into inpatient SCI/D
rehabilitation as part of standard care at Parkwood Institute. Levels of high-density
lipoprotein cholesterol (HDL-C) and triglycerides (TG) were collected to establish the
diagnoses of dyslipidemia, and HbA1c and fasting plasma glucose (FPG) values were
used to establish the diagnosis of diabetes mellitus. Cut-offs determined by published
clinical practice guidelines were used for risk stratification.1 Obesity and hypertension
screening documented during outpatient clinic appointments was collected to evaluate
screening practices at Parkwood Institute.

Definitions:
Obesity: The World Health Organization classifies a BMI of 30 kg/m2 as the obesity
cut-off for the non-SCI/D population. However, SCI/D clinical practice guidelines
recommend the use of a reduced cut-off of >22 kg/m2 to reflect changes in body
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composition in persons with SCI/D.1 Accordingly, obesity was defined as a BMI >
22kg/m2.

Hypertension: Consistent with SCI/D clinical practice guidelines, blood pressure
readings of systolic > 130 mmHg and diastolic > 85 mmHg were used to define
hypertension.1

Dyslipidemia: Dyslipidemia was defined as serum triglycerides >1.7mmol/L, or HDL-C
levels < 1.03 mmol/L or < 1.29 mmol/L for men and women, respectively, as outlined by
the SCI/D guidelines1

Diabetes Mellitus: Diabetes was defined per the clinical practice guidelines as FPG >
7mmol/L and/or glycated HbA1c  6.5%, respectively.1

CMD: The presence of 3 or more of the above risk factors was considered diagnostic for
the presence of CMD, as per the guidelines. 1

Results:
78 consecutive outpatients with SCI/D at Parkwood Institute were evaluated for CMD
risk factor prevalence. The cohort was mostly male (61.5%) with the average age 57.6
years (± 18 SD). All 4 key CMD risk factors were prevalent in the sample, with almost all
of the patients having at least one risk factor (94.9%). Even more strikingly, 75.6% had
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at least 2 CMD risk factors and 44.9% had 3 or more (44.9%), meeting the definition of
CMD.

Risk Factor Prevalence:
Obesity: BMI measurements were available for 76 patients in the sample (97.4%) and
was present in 64 (84.2%). Obesity was the most prevalent risk factor, although this
may partially be attributed to the low BMI cut-off for persons with SCI/D (BMI > 22
kg/m2). An evaluation using the conventional, non-SCI/D cut-off (BMI  30 kg/m2)
revealed that 25 patients of the sample (32.9%) met the criteria.1

Dyslipidemia: Clinical data from lipid profiles upon inpatient rehabilitation was available
for 57 patients (73.1%). Dyslipidemia was the second-most prevalent risk factor, present
in 80.7% of patients for whom data was available.

Hypertension: Hypertension screening was completed in 97.4% of patients (n=76).
47.4% of patients met the diagnostic criteria for hypertension .

Diabetes Mellitus: Screening for diabetes with fasting plasma glucose and/or HbA1c
was evaluated in 94.9% of patients (n=74). Of these, 44.6% of patients fulfilled
diagnostic criteria for diabetes mellitus.
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Frequency of Guidelines-Based Screening:
Current clinical practice guidelines recommend hypertension and obesity screening to
be completed at every routine visit and at least annually with ongoing management
respectively.1 However, to establish an overall baseline of screening completion in the
outpatient clinic at Parkwood Institute, screening for both hypertension and obesity were
assessed for completion at every appointment. Clinic intake forms completed by
physiatrists and nursing staff were reviewed to determine whether weight, height, body
mass index, and blood pressure were measured and subsequently documented. Phone
visits, conducted due to the COVID-19 pandemic, were not included in the evaluation as
the virtual nature of the assessment would limit screening without access to blood
pressure cuffs and a wheelchair-accessible weighing scale. A review of 79 in-person
clinic appointments for 43 outpatients showed that hypertension screening was
completed at 9 visits (11.4%) and obesity screening was completed at 12 visits (15.2%).
Root cause analysis and focused interviews with key stakeholders within the outpatient
clinic staff helped identify that key drivers of low screening rates were attributed to a
number of factors ranging from limited time and resources, low prioritization of CMD
risk, and to uncertainty about responsibility and appropriate methods for addressing risk
if a problem is found.

Discussion:
Two out of every 5 outpatients assessed had > 3 key modifiable CMD risk factors, and
almost all had at least one. Despite the strong indication of increased CMD risk among
this Canadian SCI/D sample, adherence to screening recommendations in the
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outpatient rehabilitation setting was found to be insufficient for hypertension and obesity
in particular. While preliminary efforts to understand the root causes underlying low
screening rates have been initiated, crucial next steps lie in building on existing
knowledge and developing comprehensive strategies to address specific barriers. One
initiative involving revisions to the outpatient clinic intake form to bring CMD risk
reduction to the forefront is underway, and an evaluation of screening completion
following its implementation will assess the intended outcome of increased screening.
Moreover, a patient-centered approach to CMD risk reduction rooted in health
promotion may prove to be beneficial to instill long-term risk-minimizing behaviours
through the maintenance of healthy lifestyle habits.9 Components of such interventions
may include but are not limited to, targeted patient education, adjusted nutrition
recommendations, and physical activity promotion in combination with behavioural
components and autonomy in decision-making.1,9,10 Ultimately, efforts to promote inhouse screening for CMD should be coupled with promoting lifestyle changes to reverse
the effects of the modifiable risk factors and maintain well-being.

Limitations:
The relatively small sample size of this single-centre initiative provides critical baseline
data about the prevalence of CMD risk factors in a Canadian SCI/D sample, consistent
with quality improvement methodology. However, results of risk factor prevalence
should be interpreted with caution as the single centre and relatively small sample size
limit generalizability. Moreover, the accuracy of diagnosing hypertension using
admission and discharge blood pressure readings rather than an average of multiple
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results taken across rehab stay has not been established, and this study did not
account for the presence or absence of antihypertensive therapy at the time of
assessment and therefore this data should be interpreted with caution. Although
methodologically sound, one limitation of this initiative is its use of SCI/D-specific cutoffs for establishing diagnosis and prevalence for obesity and dyslipidemia. The use of
SCI/D cut-offs for obesity may overestimate the true prevalence of obesity, and the use
of only triglyceride and HDL cut-offs for dyslipidemia—and not those for total cholesterol
or LDL cholesterol, as in the general population—may underestimate the prevalence of
dyslipidemia in this cohort. Although published clinical practice guidelines recommend
the use of these cut-offs to facilitate risk stratification, the guidelines and selection of
these measures are not without their own limitations.

Future Directions:
Next steps will focus on systematically introducing changes to ensure persons with
SCI/D receive appropriate, guidelines-based screening for CMD. As part of an initial
quality improvement strategy to address some of these identified root causes, a revised
clinic intake form specific to CMD risk management was developed to include key
information on the core risk factors, recommended timing for screening, and clinical
data from past evaluations to help inform treatment. Although yet to be implemented
into practice, uptake of the form may help increase CMD awareness and prioritize
prevention in the outpatient clinic setting. Other root causes to low screening brought to
attention by staff such as a lack of patient resources for self-directed learning and
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limited means of addressing CMD risk represent additional target areas for future quality
improvement initiatives.

Conclusions:
Results from this study show a strikingly high prevalence of CMD risk factors among the
sample of Canadian outpatients with SCI/D, yet screening rates far below guideline
recommendations in the outpatient clinic setting during follow-up appointments.
Ultimately, this reinforces the urgent need to develop effective quality improvement
strategies prioritizing CMD detection and management within the rehabilitation setting.
Further research is needed to develop solutions to barriers and root causes that not
only address the physiological impacts of CMD, but also target the potential
environmental, behavioural, and lifestyle factors contributing to its development.8 Efforts
to increase awareness of CMD and reinforce best practices will be vital to reducing
overall risk and promoting lifelong health in the SCI/D population.
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